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The SlIPPery SloPe oF Modern 
MedICAl rePorTInG – PArT III
with few exceptions, top scientists publish fewer, but much more important papers – Nobel Prize winners in physics, such as Albert Einstein or Richard Feynman are examples. 
Why keep repeating studies unless one is unhappy with their 
findings?
If one continually repeats studies, one is trying to get 
random chance to back them up, rather than letting science 
confirm their effectiveness.  There may be 1000 studies showing 
a positive result and 950 showing a negative result, yet the 
“positives” are considered to prevail.  Physicians often think this 
slight preponderance “proves it works”.
The more studies performed, the greater the random chance 
of success when there should be failure.  In medical statistics, 
studies are given a “statistical significance” rating, which is the 
level of confidence in the results.  It answers the question: how 
much of the results are based on chance?  A 95% confidence 
level is often used to show that a certain 
effect works, but also means there is a 5% 
probability that the result is due to chance 
alone – i.e., the “positive finding” would 
actually be false.  A higher level of statistical 
significance raising confidence to 99% 
means much more money must be spent in 
the study, requiring more subjects, and also 
possibly entailing much more failure.
There have been about 15,000 fish oil 
studies based on 95% confidence level, 
meaning that 5% x 15,000 = 750 are truly failed studies which 
show positive results by pure chance.  Therefore one should be 
wary of such enormous numbers of studies and that a negative 
finding is much stronger than a positive one.
When there is a desire to prove something, results are often 
incorrect or misinterpreted.  This happens frequently in the 
nutritional field.  Most of the recent more rigorously controlled 
studies prove fish oil doesn’t work as claimed, reversing outdated 
20th century findings.  The latest is the failure of niacin to lower 
LDL cholesterol.  Robert Giugliano of Harvard Medical School 
says that in a study of 25,000 people, niacin had not only no 
benefit, with no reductions in heart attack, stroke or death, 
but also showed higher risk of bleeding and new onset type 2 
diabetes or diabetic complications.1
Do specific measurements really mean anything?  For 
almost 50 years we have been led to believe that higher blood 
cholesterol levels accelerate atherosclerosis.  Does this mean 
… “we have over-promoted 
and overhyped thIs 
[Influenza] vaccIne.   
It does not protect as 
promoted. It’s all a sales 
job and publIc relatIons.”
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cholesterol itself is the problem, or is atherosclerosis actually 
caused by something else?  There are now doubts whether 
lowering cholesterol with a drug automatically provides health 
benefits – as we’ll see in future articles.
The influenza vaccine has been highly promoted as effective 
since 1946, but recently this vaccine has been reassessed.  By 2020, 
US health leaders want 80% of the population to be vaccinated 
annually.  This is a multibillion-dollar global business, but how 
good is the vaccine?  Scientists at the Centre for Infectious Disease 
Research and Policy at the University of Minnesota recently 
claimed that the vaccine provides only modest protection for 
healthy young and middle-aged adults, and little if any protection 
for those over 65, who are most likely to succumb to the illness 
or its complications.2 Moreover, the report’s authors concluded 
that the expansion of vaccination recommendations was based 
on inadequate evidence and poorly executed studies.  Michael T. 
Osterholm, director of both the Centre for 
Infectious Disease Research and Policy and of 
its Centre of Excellence for Influenza Research 
and Surveillance, states that “we have over-
promoted and overhyped this vaccine.  It does 
not protect as promoted. It’s all a sales job 
and public relations”.  He continues, “I’m an 
insider.  Until we started this project, I was 
one of the people out there heavily promoting 
it.  It was only with this study that I looked 
and said, what are we doing?”
Dr Osterholm said the authors discovered a recurring error 
in influenza vaccine studies that led to an exaggeration of the 
vaccine’s effectiveness.  They also discovered 30 inaccuracies in 
the statement on influenza vaccines put forth by the expert panel 
that develops vaccine recommendations, all of which favour the 
vaccine. 
Medical researchers, just like professionals in other fields, are 
often highly motivated by status and rewards, and are often not 
objective.  They can dogmatically defend an incorrect idea, even 
if they didn’t originate it.  Researchers linked to multi-billion 
industries are a particular risk to transparent correct science. 
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